The potential utility of other markers to further enhance sensitivity are presented Conclusion: We conclude that an era of combined modality testing in thyroid cytology is emerging where classical cytologic findings can be coupled with molecular data to increase the predictive power of our diagnostic interpretations, but that there remains a group of atypical cytologic samples negative for known molecular markers in which the risk of malignancy is too high to ignore completely.